European Institute of Oncology

NCT06364267

CollaboratorPhase 2Recruiting2025140 people15 Apr 2024clinicaltrials.gov

NCT06033092

Phase 2Completed2024110 people13 Sept 2023clinicaltrials.gov

NCT04248998

CollaboratorPhase 2Status unknown202030 people30 Jan 2020clinicaltrials.gov

NCT02305810

Phase 2Completed201354 people3 Dec 2014clinicaltrials.gov

NCT01579734

Phase 3Status unknown20021,884 people18 Apr 2012clinicaltrials.gov

NCT01500577

Phase 2Completed2005150 people28 Dec 2011clinicaltrials.gov

NCT01374841

Phase 2Status unknown201020 people16 Jun 2011clinicaltrials.gov

NCT01357772

CollaboratorPhase 3Active, not recruiting2008500 people23 May 2011clinicaltrials.gov

NCT01281787

Phase 3Completed2008320 people24 Jan 2011clinicaltrials.gov

NCT01264874

Phase 3Terminated2010150 people22 Dec 2010clinicaltrials.gov

NCT00002897

Phase 3Completed1992240 people3 Sept 2004clinicaltrials.gov

NCT00002747

Phase 3Status unknown1992240 people23 Jun 2004clinicaltrials.gov

NCT00002896

Phase 3Status unknown1993774 people13 May 2004clinicaltrials.gov

NCT00003053

Phase 3Status unknown1994750 people27 Jan 2003clinicaltrials.gov

NCT00002720

Phase 3Completed1995642 people27 Jan 2003clinicaltrials.gov

NCT00002702

Phase 3Status unknown1992260 people27 Jan 2003clinicaltrials.gov

Hydroxytyrosol and Olive-Derived Hydroxytyrosol-Rich Products for Skin Health and Prevention of Skin Ageing: Current Evidence and Future Perspectives

31 Aug 2026pubmed.ncbi.nlm.nih.gov